1. |
Campbell BCV, Khatri P. Stroke. Lancet, 2020, 396(10244): 129-142.
|
2. |
Feigin VL, Nguyen G, et al. Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016. N Engl J Med, 2018, 379(25): 2429-2437.
|
3. |
王亚楠, 吴思缈, 刘鸣. 中国脑卒中 15 年变化趋势和特点. 华西医学, 2021, 36(6): 803-807.
|
4. |
郭文, 吴思缈, 刘鸣. 提倡强化危重症脑梗死分类分期预防意识. 华西医学, 2021, 36(6): 701-706.
|
5. |
Paciaroni M, Bogousslavsky J. Primary and secondary prevention of ischemic stroke. Eur Neurol, 2010, 63(5): 267-278.
|
6. |
Smith CJ, Emsley HC, Vail A, et al. Variability of the systemic acute phase response after ischemic stroke. J Neurol Sci, 2006, 251(1/2): 77-81.
|
7. |
Verma S, Yeh ET. C-reactive protein and atherothrombosis-beyond a biomarker: an actual partaker of lesion formation. Am J Physiol Regul Integr Comp Physiol, 2003, 285(5): R1253-1256.
|
8. |
Pedersen ED, Waje-Andreassen U, Vedeler CA, et al. Systemic complement activation following human acute ischaemic stroke. Clin Exp Immunol, 2004, 137(1): 117-122.
|
9. |
VanGilder RL, Davidov DM, Stinehart KR, et al. C-reactive protein and long-term ischemic stroke prognosis. J Clin Neurosci, 2014, 21(4): 547-553.
|
10. |
Di Napoli M, Schwaninger M, Cappelli R, et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke, 2005, 36(6): 1316-1329.
|
11. |
Matsuo R, Ago T, Hata J, et al. Plasma C-reactive protein and clinical outcomes after acute ischemic stroke: a prospective observational study. PLoS One, 2016, 11(6): e0156790.
|
12. |
Karlinski M, Bembenek J, Grabska K, et al. Routine serum C-reactive protein and stroke outcome after intravenous thrombolysis. Acta Neurol Scand, 2014, 130(5): 305-311.
|
13. |
Topakian R, Strasak AM, Nussbaumer K, et al. Prognostic value of admission C-reactive protein in stroke patients undergoing IV thrombolysis. J Neurol, 2008, 255(8): 1190-1196.
|
14. |
Zhao Y, Hu Y, Smith J P, et al. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol, 2014, 43(1): 61-68.
|
15. |
Berkley A, Ferro A. Changes in C-reactive protein in response to anti-inflammatory therapy as a predictor of cardiovascular outcomes: a systematic review and meta-analysis. JRSM Cardiovasc Dis, 2020, 9: 2048004020929235.
|
16. |
Wang L, Li Y, Wang C, et al. C-reactive protein, infection, and outcome after acute ischemic stroke: a registry and systematic review. Curr Neurovasc Res, 2019, 16(5): 405-415.
|
17. |
Borowicz W, Ptaszkowski K, Ptaszkowska L, et al. Assessment of changes in serum C-reactive protein levels in patients after ischemic stroke undergoing rehabilitation-a retrospective observational study. J Clin Med, 2023, 12(3): 1029.
|
18. |
Shoaeb MA, Shehata MA, Taema KM, et al. CRP in cerebrovascular stroke: prognostic implications. Egypt J Crit Care Med, 2014, 2(1): 43-52.
|
19. |
Wnuk M, Derbisz J, Drabik L, et al. C-reactive protein and white blood cell count in non-infective acute ischemic stroke patients treated with intravenous thrombolysis. J Clin Med, 2021, 10(8): 1610.
|
20. |
Montaner J, Fernandez-Cadenas I, Molina CA, et al. Poststroke C-reactive protein is a powerful prognostic tool among candidates for thrombolysis. Stroke, 2006, 37(5): 1205-1210.
|